ONCT

Oncternal Therapeutics, Inc. Common Stock
ONCT

Overview Fund Activity
Delisted

ONCT was delisted on the 2nd of December, 2024.

Back to rankings

26 hedge funds and large institutions have $7.1M invested in Oncternal Therapeutics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 1 closing their positions.

Holders
26
Holders Change
+3
Holders Change %
+13.04%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
NCM
1
Nantahala Capital Management
Connecticut
$2.04M
2
OM
2
Opaleye Management
Massachusetts
$331K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$251K
4
AC
4
Armistice Capital
New York
$2.24M
5
Morgan Stanley
5
Morgan Stanley
New York
$46K

Top Sellers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$473K
2
MAM
2
Meeder Asset Management
Ohio
$0
3
State Street
3
State Street
Massachusetts
$30K
4
BlackRock
4
BlackRock
New York
$110K
5
Millennium Management
5
Millennium Management
New York
$60
Name Market Value Shares Shares
Change 		Shares
Change %
CFGS
26
Concourse Financial Group Securities
Alabama
– – – –
Group One Trading
27
Group One Trading
Illinois
$0 191 – –
Wells Fargo
28
Wells Fargo
California
$0 66 +5 +8%
1
2